As of 12:32 PM on the 18th, Shinpung Pharmaceutical is trading at 19,650 KRW, down 3.2% from the previous day. This represents a 24.37% increase compared to April 16. Shinpung Pharmaceutical is known as a pharmaceutical company focused on the sale of specialized therapeutic drugs.

Over the past five days, individual investors have net purchased 8,652 shares, while foreigners and institutions have net sold 8,711 shares and net purchased 21,326 shares, respectively.

On May 14, Shinpung Pharmaceutical became a market topic with the announcement of "Malaria treatment drug COVID-19 Phase 2 clinical trial approval (comprehensive)."

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing